MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry

Recruiting now

Conditions studied: Aortic Valve Stenosis

In brief

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.

Key facts

Study ID

NCT06804148

Run by

Prof. Dr. med. Ingo Eitel

People needed

2000

Starts

2025-01-01

Expected to finish

2030-12-30

Last updated by the study team

2025-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is going to be treated with Myval THV
• Age ≥ 18 years
• Ability to give informed consent

You may not qualify if…

• Pregnant and lactating women
• Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media.
• Patients in whom anti-platelet and/or anticoagulant therapy are contra-indicated.
• Any condition, which in the Investigator's opinion, would preclude safe participation of patient in the registry

Where it is running

• Universitätsklinikum Schleswig-Holstein - Campus Lübeck — Lübeck, Schleswig-Holstein, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.